Pmu92 - Can the Eq-5d-3l Predict Post-Hospitalization Healthcare Use and Outcomes?

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.1928
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

A Comparison of the EQ-5D-3L and EQ-5D-5L

PharmacoEconomics
Health PolicyPublic HealthOccupational HealthPharmacologyEnvironmental
2020English

Comparing Responsiveness of the EQ-5D-5L, EQ-5D-3L and EQ VAS in Stroke Patients

Quality of Life Research
EnvironmentalPublic HealthOccupational Health
2014English

Head-To-Head Comparison of EQ‐5D‐3L and EQ‐5D‐5L Health Values

PharmacoEconomics
Health PolicyPublic HealthOccupational HealthPharmacologyEnvironmental
2018English

Pih53 - Comparison of the Eq-5d-5l and the Eq-5d-3l Using Individual Patient Data From Reform Trial

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Pmu89 - European Union 5 (Eu5) Norms for the 3-Level Eq-5d (Eq-5d-3l) Questionnaire

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Measurement Properties of the EQ-5D-5L Compared to EQ-5D-3L in the Thai Diabetes Patients

Health and Quality of Life Outcomes
MedicineEnvironmentalPublic HealthOccupational Health
2015English

Ql3 - Eq-5d-5l Is More Responsive Than Eq-5d-3l to Treatment Benefit of Cataract Surgery

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

How Do EQ-5D-3L and EQ-5D-5L Compare in a Swedish Total Hip Replacement Population?

Acta Orthopaedica
MedicineSurgeryOrthopedicsSports Medicine
2020English

Prm169 - Responsiveness of the Eq-5d-5l and Eq-5d-3l in Patients Following Total Hip or Knee Replacement

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy